Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
AssigneeCellular Genomics, Inc.
InventorsKevin S. Currie, Robert W. DeSimone, Douglas A. Pippin, James W. Darrow, Scott A. Mitchell
Life of this patent
Estimating the term…
Abstract
A novel composition comprises a compound of Formula 1 1 the pharmaceutically acceptable salts, hydrates, solvates, crystal forms, diastereomers, prodrugs, or mixtures thereof. The composition is of particular utility in the treatment of kinase-implicated disorders.
Claims57
A compound having of Formula 1
- 11
- a pharmaceutically acceptable salt, hydrates, solvate, crystal form, diastereomer, prodrug, or mixture thereof, wherein
- R1 is hydrogen;
- cyclo-(C3-C6 alkyl)-methyl;
- straight or branched chain C1-C7 alkyl, in which the branched alkyl chains may form a 3 to 7 member heteroalkyl or alkyl ring;
- sulfonamide;
- C1-C6 alkoxy;
- (C1-C6)-alkyl-oxy-(C1-C6)alkoxy;
- mono- or di(C1-C6 alkyl)amino;
- mono- or di(C1-C6 alkyl)amino(C1-C6 alkyl);
- or phenyl or heteroaryl ring which may be unsubstituted, or mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, sulfonamide, halogen, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, mono- or di(C1-C6 alkyl)amino, or mono- or di(C1-C6 alkyl)amino(C1-C6 alkyl);
- and,
- R2 is straight or branched chain C1-C7 alkyl, in which the branched alkyl chains may form a 3-7 member heteroalkyl or alkyl ring;
- cyclo-(C3-C6 alkyl)-methyl;
- C1-C6 alkoxy, except when Z2 is phenylene and A is 0 and R1 is straight or branched chain C1-C7 alkyl (but not cycloalkyl), phenyl, or phenyl substituted with hydroxy, nitro, cyano, amino, C1-C6 alkoxy, or halogen, or when A is 1 and Z1 is —C(R4)(R5)— wherein m is 1, 2, or 3 and R1 is straight or branched chain C1-C7 alkyl (but not cycloalkyl), phenyl, or phenyl substituted with hydroxy, nitro, cyano, amino, C1-C6 alkoxy, or halogen, or when Z2 is phenylene, A is 1, Z, is —C(R4)(R5)— wherein m is 1, 2, or 3, and R1 is straight or branched chain C1-C7 alkyl (but not cycloalkyl), phenyl, or phenyl substituted with hydroxy, nitro, cyano, amino, C1-C6 alkoxy, or halogen, or when Z2 is —C(R7)(R8)— wherein n is 1, 2, or 3, each occurrence of R7 and R8 is independently straight or branched chain C1-C6 alkyl or halogen and R2 is C1-C6 alkoxy or phenyl substituted with nitro;
- (C1-C6)-alkyl-oxy-(C1-C6)alkoxy;
- or phenyl or heteroaryl which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro (except when Z2 is phenylene and A is 0 and R1 is straight or branched chain C1-C7 alkyl (but not cycloalkyl), phenyl, or phenyl substituted with hydroxy, nitro, cyano, amino, C1-C6 alkoxy, or halogen, or when A is 1 and Z, is —C(R4)(R5)— wherein m is 1, 2, or 3, and R1 is straight or branched chain C1-C7 alkyl (but not cycloalkyl), phenyl, or phenyl substituted with hydroxy, nitro, cyano, amino, C1-C6 alkoxy, or halogen, or when Z2 is phenylene and A is 1 and Z, is —C(R4)(R5)— wherein m is 1, 2, or 3, and R1 is straight or branched chain C1-C7 alkyl (but not cycloalkyl), phenyl, or phenyl substituted with hydroxy, nitro, cyano, amino, C1-C6 alkoxy, or halogen, or when Z2 is —C(R7)(R8)— wherein n is 1, 2, or 3, each occurrence of R7 and R8 is independently straight or branched chain C1-C6 alkyl or halogen and R2 is C1-C6 alkoxy or phenyl substituted with nitro), cyano, amino, halogen, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or amino(C1-C6 alkyl);
- phenyoxy phenyl where each phenyl may be independently unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, sulfonamide, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or amino(C1-C6 alkyl);
- phenyl or heteroaryl piperazine where the phenyl or heteroaryl ring may be independently unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, sulfonamide, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or mono- or di(C1-C6 alkyl)amino(C1-C6 alkyl);
- R3 is hydrogen;
- straight or branched chain C1-C7 alkyl, in which the branched alkyl chains may form a 3-7 member heteroalkyl or alkyl ring;
- Z1 is
- 12
- wherein
- A is 0 or 1;
- each occurrence of R4 and R5 is independently hydrogen, straight or branched chain C1-C6 alkyl, sulfonamide, or halogen;
- m is 0, 1, or 2;
- and
- R6 is hydrogen;
- straight or branched chain C1-C6 alkyl;
- phenyl which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or amino(C1-C6 alkyl);
- or heteroaryl which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or amino(C1-C6 alkyl);
- and
- Z2 is a divalent linking group selected from para-phenylene, meta-phenylene, ortho-phenylene, naphthylene,
- 13
- wherein
- each occurrence of R7 and R8 is independently straight or branched chain C1-C6 alkyl, sulfonamide, or halogen;
- n is 1, 2, or 3;
- and
- R9-R12 are each independently hydrogen;
- straight or branched chain C1-C6 alkyl;
- phenyl which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- of di(C1-C6 alkyl)amino, or amino(C1-C6 alkyl);
- or heteroaryl which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, (C1-C6)-alkyl-oxy-(Ci -C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or amino(C1-C6 alkyl).
A compound having Formula 2
- 14
- a pharmaceutically acceptable salt, hydrates, solvate, crystal form, diastereomer, prodrug, or mixture thereof, wherein
- R1 is hydrogen;
- cyclo-(C3-C6 alkyl)-methyl;
- straight or branched chain C1-C7 alkyl, in which the branched alkyl chains are allowed to also form a 3-7 member heteroalkyl or alkyl ring;
- sulfonamide;
- C1-C6 alkoxy;
- (C1-C6)-alkyl-oxy-(C1-C6)alkoxy;
- mono- or di(C1-C6 alkyl)amino, or mono- or di(C1-C6 alkyl)amino(C1-C6 alkyl);
- or phenyl or heteroaryl ring which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, sulfonamide, halogen, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, mono- or di(C1-C6 alkyl)amino, or mono- or di(C1-C6 alkyl)amino(C1-C6 alkyl);
- R2 in Formula 2 is straight or branched chain C1-C7 alkyl, in which the branched alkyl chains are allowed to also form a 3-7 member heteroalkyl or alkyl ring;
- cyclo-(C3-C6 alkyl)-methyl;
- C1-C6 alkoxy except when A is 0 and R1 is straight or branched chain C1-C7 alkyl (but not cycloalkyl), phenyl, or phenyl substituted with hydroxy, nitro, cyano, amino, C1-C6 alkoxy, or halogen, or when A is 1 and Z, is —C(R4)(R5)— wherein m is 1, 2, or 3 and R1 is straight or branched chain C1-C7 alkyl (but not cycloalkyl), phenyl, or phenyl substituted with hydroxy, nitro, cyano, amino, C1-C6 alkoxy, or halogen;
- (C1-C6)-alkyl-oxy-(C1-C6)alkoxy;
- phenyl or heteroaryl which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro (except when A is 0 and R1 is straight or branched chain C1-C7 alkyl (but not cycloalkyl), phenyl, or phenyl substituted with hydroxy, nitro, cyano, amino, C1-C6 alkoxy, or halogen, or when A is 1 and Z, is —C(R4)(R5)— wherein m is 1, 2, or 3, and R1 is straight or branched chain C1-C7 alkyl (but not cycloalkyl), phenyl, or phenyl substituted with hydroxy, nitro, cyano, amino, C1-C6 alkoxy, or halogen), cyano, amino, halogen, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl- oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, amino(C1-C6 alkyl);
- phenyoxy phenyl where each phenyl may be independently unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, sulfonamide, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or amino(C1-C6 alkyl);
- or phenyl or heteroaryl piperazine where the phenyl or heteroaryl ring may be independently unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, sulfonamide, C1-C6 alkyl, C1-C6 perfluoroalkyl, CI -C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(Ci -C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or mono- or di(C1-C6 alkyl)amino(C1-C6 alkyl);
- R3 in Formula 2 may be hydrogen;
- straight or branched chain C1-C7 alkyl, in which the branched alkyl chains can also form a 3-7 member heteroalkyl or alkyl ring;
- A in Formula 2 is 0 or 1;
- and
- Z, in Formula 2 is
- 15
- wherein
- each occurrence of R4and R5 is independently hydrogen, straight or branched chain C1-C6 alkyl, sulfonamide, or halogen;
- m is 1, 2, or 3;
- and
- R6 is hydrogen;
- straight or branched chain C1-C6 alkyl;
- phenyl, which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or amino(C1-C6 alkyl);
- or heteroaryl, which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, C1-C6 alky, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or amino(C1-C6 alkyl).
A compound having Formula 3:
- 16
- a pharmaceutically acceptable salt, hydrates, solvate, crystal form, diastereomer, prodrug, or mixture thereof, wherein
- a is 0, 1, 2 or 3;
- R14 is hydrogen;
- cyclo-(C3-C6 alkyl)-methyl;
- straight or branched chain C1-C6 alkyl, in which the branched alkyl chains may form a 3-7 member heteroalkyl or alkyl ring;
- sulfonamide;
- C1-C6 alkoxy;
- (C1-C6)-alkyl-oxy-(C1-C6)alkoxy;
- mono- or di(C1-C6 alkyl)amino, mono- or di(C1-C6 alkyl)amino(C1-C6 alkyl);
- or phenyl or heteroaryl ring, which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, sulfonamide, halogen, C1-C6 alkyl, Ci -C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, mono- or di(C1-C6 alkyl)amino, or mono- or di(C1-C6 alkyl)amino(C1-C6 alkyl);
- R2 in Formula 3 is straight or branched chain C1-C6 alkyl, in which the branched alkyl chains may form a 3-7 member heteroalkyl or alkyl ring;
- cyclo-(C3-C6 alkyl)-methyl;
- C1-C6 alkoxy except where R1 is hydrogen, C1-C6 alkoxy, or phenyl substituted with nitro;
- (C1-C6)-alkyl-oxy-(C1-C6)alkoxy;
- phenyl or heteroaryl, which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or amino(C1-C6 alkyl);
- phenyoxy phenyl, in which each phenyl may be independently unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro (except where R1 is hydrogen, C1-C6 alkoxy, or phenyl substituted with nitro), cyano, amino, halogen, sulfonamide, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or amino(C1-C6 alkyl);
- or phenyl or heteroaryl piperazine, in which the phenyl or heteroaryl ring may be independently unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, sulfonamide, C1-C6 alkyl, C1-C6 perfluoroalkyl, C1-C6 perfluoroalkoxy, C1-C6 alkoxy, (C1-C6)-alkyl-oxy-(C1-C6)alkoxy, mono- or di(C1-C6 alkyl)amino, or mono- or di(C1-C6 alkyl)amino(C1-C6 alkyl);
- and
- R3 is hydrogen;
- straight or branched chain C1-C6 alkyl, in which the branched alkyl chains may form a 3-7 member heteroalkyl or alkyl ring.
A compound according to claim embodiment 1, or a pharmaceutically acceptable salt, hydrate, solvate, crystal form, diastereomer, or prodrug thereof, wherein the compounds is 4-{6-[4-(piperidine-1-carbonyl)-phenyl]-imidazo[1,2-a]pyrazin-8-ylamino}-benzoic acid ethyl ester.
Dependencies are inferred from the claim text.